NCT01244230 Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Atopic Dermatitis (AD) Status COMPLETED Phase PHASE2/PHASE3
NCT01234909 Asthma, Missed Immunizations, and Vitamin D Deficiency in Atopic Dermatitis Status TERMINATED Phase N/A
NCT01232985 Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults Status COMPLETED Phase PHASE2
NCT01232543 Safety Study Evaluating the Adrenal Suppression Potential of Product 0405 in Pediatric Subjects With Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT01231854 Ciclosporin Versus Alitretinoin for Severe Atopic Hand Dermatitis. Status TERMINATED Phase PHASE4
NCT01228513 Efficacy and Safety of Different Concentrations of ZK245186 in Atopic Dermatitis (AD) Status COMPLETED Phase PHASE2
NCT01223222 A Study to Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin Infection Status COMPLETED Phase PHASE2
NCT01202149 Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic Dermatitis Status COMPLETED Phase PHASE4
NCT01179880 A Study of E6005 in Japanese Patients With Atopic Dermatitis Status COMPLETED Phase PHASE1/PHASE2
NCT01179529 Atopic Dermatitis Biomarker Identification Trial in Omalizumab Usage Status COMPLETED Phase PHASE2
NCT01177566 Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis. Status COMPLETED Phase PHASE4
NCT01174511 Evaluation of A-1 Cool Cream Efficacy for Treatment Atopic Dermatitis Status UNKNOWN Phase PHASE1/PHASE2
NCT01149759 Reversal of Epidermal Phenotype in Severe Atopic Dermatitis With Cyclosporine Therapy Status COMPLETED Phase NA
NCT01139450 Study of 0417 Ointment in the Treatment of Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT01138761 Health Literacy for Children With Atopic Dermatitis and Their Caregivers Status TERMINATED Phase NA
NCT01137032 Study to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult Population Status COMPLETED Phase PHASE4